Who Will Benefit from Charged-Particle Therapy?
Kyung Su Kim, Hong-Gyun Wu
Cancer Res Treat. 2021;53(3):621-634. Published online 2021 Jun 21 DOI: https://doi.org/10.4143/crt.2021.299
Citations to this article as recorded by 
Radiation-targeted immunotherapy: A new perspective in cancer radiotherapy
Lihui Xuan, Chenjun Bai, Zhao Ju, Jinhua Luo, Hua Guan, Ping-Kun Zhou, Ruixue Huang
Cytokine & Growth Factor Reviews.2024; 75: 1. CrossRef
Cellular irradiations with laser-driven carbon ions at ultra-high dose rates
Pankaj Chaudhary, Giuliana Milluzzo, Aodhan McIlvenny, Hamad Ahmed, Aaron McMurray, Carla Maiorino, Kathryn Polin, Lorenzo Romagnani, Domenico Doria, Stephen J McMahon, Stanley W Botchway, Pattathil P Rajeev, Kevin M Prise, Marco Borghesi
Physics in Medicine & Biology.2023; 68(2): 025015. CrossRef
Efficacy and safety of particle therapy for inoperable stage II-III non-small cell lung cancer: a systematic review and meta-analysis
Yanliang Chen, Hongtao Luo, Ruifeng Liu, Mingyu Tan, Qian Wang, Xun Wu, Tianqi Du, Zhiqiang Liu, Shilong Sun, Qiuning Zhang, Xiaohu Wang
Radiation Oncology.2023;[Epub] CrossRef
Particle radiotherapy in the era of radioimmunotherapy
Zihan Zhou, Bingjie Guan, Huang Xia, Rong Zheng, Benhua Xu
Cancer Letters.2023; 567: 216268. CrossRef
The Rise of Particle Beam Therapy: Are We Ready for The Potential Game-Changer?
Eui Kyu Chie, Yong Chan Ahn
Cancer Research and Treatment.2021; 53(3): 609. CrossRef